MiR-17-5p Modulates Osteoblastic Differentiation and Cell Proliferation by Targeting SMAD7 in Non-traumatic Osteonecrosis

Overview

Journal Exp Mol Med

Specialties Biochemistry
Molecular Biology

Date 2014 Jul 26

PMID 25060766

Citations 57

Authors

Jie Jia

Xiaobo Feng

Weihua Xu

Shuhua Yang

Qing Zhang

Xianzhe Liu

Yong Feng

Zhipeng Dai

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) have recently been recognized to have a role in human orthopedic disorders. The objective of our study was to explore the expression profile and biological function of miRNA-17-5p (miR-17-5p), which is well known to be related to cancer cell proliferation and invasion, in osteoblastic differentiation and in cell proliferation. The expression levels of miR-17-5p in the femoral head mesenchymal stem cells of 20 patients with non-traumatic osteonecrosis (ON) and 10 patients with osteoarthritis (OA) were examined by quantitative reverse transcription-PCR (qRT-PCR). Furthermore, the interaction between miR-17-5p and SMAD7 was observed. We found that in non-traumatic ON samples the level of mature miR-17-5p was significantly lower than that of OA samples (P=0.0002). By targeting SMAD7, miR-17-5p promoted nuclear translocation of β-catenin, enhanced expression of COL1A1 and finally facilitated the proliferation and differentiation of HMSC-bm cells. We also demonstrated that restoring expression of SMAD7 in HMSC-bm cells partially reversed the function of miR-17-5p. Together, our data suggested a theory that dysfunction of a network containing miR-17-5p, SMAD7 and β-catenin could contribute to ON pathogenesis. The present study prompts the potential clinical value of miR-17-5p in non-traumatic ON.

Citing Articles

Overexpression of miR17 ~ 92 in Myeloid Cells in Mice Increased Bone Mass Through Reduced Bone Resorption and Increased Bone Formation in Sex-Dependent Manner.

Sheng M, Stiffel V, Taipia J, Rundle C, Lau K Calcif Tissue Int. 2025; 116(1):9.

PMID: 39751939 PMC: 11698891. DOI: 10.1007/s00223-024-01325-x.

Translational horizons in stem cell therapy for osteonecrosis of the femoral head: a journey from basic research to clinical practice through bibliometric insights.

Wu T, Zhou Y, Shi W, Guo S, Tian H, Li W J Transl Med. 2024; 22(1):982.

PMID: 39478610 PMC: 11523765. DOI: 10.1186/s12967-024-05784-6.

Advances in mechanism and management of bone homeostasis in osteonecrosis: a review article from basic to clinical applications.

Xiang X, He H, He C Int J Surg. 2024; 111(1):1101-1122.

PMID: 39311934 PMC: 11745759. DOI: 10.1097/JS9.0000000000002094.

Unveiling Mesenchymal Stem Cells' Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications.

Jankowski M, Farzaneh M, Ghaedrahmati F, Shirvaliloo M, Moalemnia A, Kulus M Cells. 2023; 12(21).

PMID: 37947637 PMC: 10649218. DOI: 10.3390/cells12212559.

Fibroblast growth factor 23 regulates hypoxia‑induced osteoblast apoptosis through the autophagy‑signaling pathway.

Yin Q, Yang H, Fang L, Wu Q, Gao S, Wu Y Mol Med Rep. 2023; 28(5).

PMID: 37711045 PMC: 10540001. DOI: 10.3892/mmr.2023.13086.

References

Yamasaki K, Nakasa T, Miyaki S, Yamasaki T, Yasunaga Y, Ochi M . Angiogenic microRNA-210 is present in cells surrounding osteonecrosis. J Orthop Res. 2012; 30(8):1263-70. DOI: 10.1002/jor.22079. View

Hossain A, Kuo M, Saunders G . Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol. 2006; 26(21):8191-201. PMC: 1636750. DOI: 10.1128/MCB.00242-06. View

Lee R, Ambros V . An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001; 294(5543):862-4. DOI: 10.1126/science.1065329. View

Attisano L, Wrana J . Signal transduction by the TGF-beta superfamily. Science. 2002; 296(5573):1646-7. DOI: 10.1126/science.1071809. View

Nishimori S, Tanaka Y, Chiba T, Fujii M, Imamura T, Miyazono K . Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in osteoblastic cells. J Biol Chem. 2001; 276(14):10700-5. DOI: 10.1074/jbc.M007499200. View

Fontana L, Fiori M, Albini S, Cifaldi L, Giovinazzi S, Forloni M . Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One. 2008; 3(5):e2236. PMC: 2375057. DOI: 10.1371/journal.pone.0002236. View

Ahmed F, Ahmed N, Vos P, Bonnerup C, Atkins J, Casey M . Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics. 2013; 10(3):93-113. View

Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H . Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene. 2007; 26(41):6099-105. DOI: 10.1038/sj.onc.1210425. View

Zhang M, Yan Y, Lim Y, Tang D, Xie R, Chen A . BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J Cell Biochem. 2009; 108(4):896-905. PMC: 2837602. DOI: 10.1002/jcb.22319. View

10.

Jiang S, Zu Y, Fu Y, Zhang Y, Efferth T . Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol. 2008; 33(1):103-11. View

11.

Mont M, Marulanda G, Jones L, Saleh K, Gordon N, Hungerford D . Systematic analysis of classification systems for osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006; 88 Suppl 3:16-26. DOI: 10.2106/JBJS.F.00457. View

12.

Yan Z, Hang D, Guo C, Chen Z . Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res. 2008; 27(4):442-6. DOI: 10.1002/jor.20759. View

13.

Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K . TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun. 2007; 356(4):1004-10. DOI: 10.1016/j.bbrc.2007.03.099. View

14.

Lee J, Kim B, Ahn J, Park H, Park S, Yoo J . Role of PI3K on the regulation of BMP2-induced beta-Catenin activation in human bone marrow stem cells. Bone. 2010; 46(6):1522-32. DOI: 10.1016/j.bone.2010.02.013. View

15.

Zhang N, Wei P, Gong A, Chiu W, Lee H, Colman H . FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011; 20(4):427-42. PMC: 3199318. DOI: 10.1016/j.ccr.2011.08.016. View

16.

Lee J, Lee J, Roh H, Kim C, Jung J, Suh K . Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J Orthop Res. 2006; 24(4):604-9. DOI: 10.1002/jor.20078. View

17.

van Wijnen A, van de Peppel J, van Leeuwen J, Lian J, Stein G, Westendorf J . MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep. 2013; 11(2):72-82. PMC: 3678273. DOI: 10.1007/s11914-013-0143-6. View

18.

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

19.

Ukai T, Sato M, Akutsu H, Umezawa A, Mochida J . MicroRNA-199a-3p, microRNA-193b, and microRNA-320c are correlated to aging and regulate human cartilage metabolism. J Orthop Res. 2012; 30(12):1915-22. DOI: 10.1002/jor.22157. View

20.

Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science. 2001; 294(5543):853-8. DOI: 10.1126/science.1064921. View